期刊文献+

扶正解毒方治疗儿童持续性、慢性免疫性血小板减少症临床疗效分析 被引量:3

Clinical effect of Fuzheng Jiedu Decoction in treating children with persistent and chronic immune thrombocytopenia
下载PDF
导出
摘要 目的总结扶正解毒方治疗儿童持续性、慢性免疫性血小板减少症(ITP)的临床疗效。方法回顾分析本院近两年就诊的持续性、慢性ITP患儿52例,予扶正解毒方治疗6个月后的出血情况及血小板计数,继续随访2个月。结果(1)治疗前与治疗3、6个月后出血症状评分分别是(0.98±1.163)、(0.29±0.696)和(0.13±0.525)。(2)治疗前与治疗3、6个月后血小板计数分别为(38.48±23.859)×10^9/L、(72.35±50.103)×10^9/L和(81.38±54.212)×10^9/L,差异有显著性(P<0.05)。(3)治疗3个月后,完全反应率11.5%,总有效率36.5%;治疗6个月后,分别增至28.8%和53.8%。(4)随访2个月,45例(86.5%)患儿完成随访,完全反应率40.0%,总有效率62.2%。结论扶正解毒方治疗儿童持续性、慢性ITP,可改善患儿出血症状,提升血小板计数。 Objective To analyze the clinical efficacy of Fuzheng Jiedu Decoction in treating children with persistent and chronic immune thrombocytopenia(ITP).Methods A retrospective analysis of 52 children with persistent and chronic ITP treated in our hospital in the past 2 years was performed.After 6 months of treatment with Fuzheng Jiedu Decoction,the efficacy was calculated and followed up for 2 months.Results(1)The bleeding symptom score before and after 3 and 6 months treatment was 0.98±1.163,0.29±0.696 and 0.13±0.525,respectively.(2)Before and after 3 and 6 months treatment,the platlet count was(38.48±23.859)×10^9/L,(72.35±50.103)×10^9/L and(81.38±54.212)×10^9/L,respectively(P<0.05).(3)After 3 months,the complete response rate was 11.5%and the total effective rate was 36.5%;after 6 months,the complete response rate was 28.8%and the total effective rate was 53.8%.(4)After 2 months of follow-up,45 cases(86.5%)completed the follow-up.The complete response rate was 40.0%,and the total effective rate was 62.2%.Conclusions Fuzheng Jiedu Decoction has a good clinical effect on the improvement of the platelet count and improves the bleeding symptoms of children with persistent and chronic ITP.
作者 徐悠 余惠平 许雪雪 胡淼 杨剑峰 张晓倩 李靖 李豪 XU You;YU Huiping;XU Xuexue;HU Miao;YANG Jianfeng;ZHANG Xiaoqian;LI Jing;LI Hao(First Clinical School of Medicine, Beijing University of Chinese Medicine. Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, China)
出处 《中国小儿血液与肿瘤杂志》 CAS 2020年第6期339-342,共4页 Journal of China Pediatric Blood and Cancer
基金 首都临床特点应用研究与成果推广(Z171100001017224)。
关键词 扶正解毒方 免疫性血小板减少症 儿童 Fuzheng Jiedu Decoction Immune thrombocytopenia Children
  • 相关文献

参考文献4

二级参考文献42

  • 1Ruggeri M, Fortuna S, Rodeghiero F. Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature. Haematologica,2008 ,93 :98-103.
  • 2Rodeghiero F, Stasi R, Gernsheimer T,et al. Standardization of terminology, definitions and outcome criteria in imnmne thrombocytopenic purpura of adults and children: report from an international working group. Blood,2009,113:2386-2393.
  • 3Bromberg ME. Immune thrombocytopenic purpura--the changing therapeutic landscape. N Engl J Med,2006,355:1643-1645.
  • 4Rosth S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic puvpura in children: a prospective nordic study of an unselected cohort. J Pediatr, 2003,143 : 302-307.
  • 5Ktihne T, Buchanan GR, Zimmerman S, et al. Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thromhocytopenic purpura ( ITP ) from the Intercontinental Childhood ITP Study Group. J Pediatr,2003, 143:605-608.
  • 6Fujisawa K, Iyori H, Ohkawa H, et al. Japanese Study Group on Childhood ITP. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Int J Hematol ,2000 ,72 :376-383.
  • 7British Committee tor Standards in Hematology General Hematology Task Fo~e. Guidelines for the investigation and management of idiopathicthrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol, 2003, 120: 574-596.
  • 8Kuwana M, Okazaki Y, Satoh T,et al. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med 2005,118 : 1026-1033.
  • 9Gouin-Thibauh I, Cassinat B, Chomienne C, et al. Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span. Clin Chem,2001, 47 : 1660-1665.
  • 10Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic disease. Acta Paediatr, 2005,94:175-184.

共引文献128

同被引文献72

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部